Literature DB >> 31127444

Accuracy Enhanced Lung Cancer Prognosis for Improving Patient Survivability Using Proposed Gaussian Classifier System.

Kaviarasi R1, Gandhi Raj R2.   

Abstract

Statistical classifier and good accuracy is an essential part of the research in medical data mining. Accurate prediction of lung cancer is an essential step for making effective clinical decisions. After identifying the lung cancer, minimum scopes are available in the medications for patient living in the world. Hemoglobin level and TNM stage wise patients survival period has to be varied. Some group of people survival period is minimal and another group of people survival time is lengthy. This study is aimed to develop a prediction model with new clinical variables to predict lung cancer patients. It's based on revised 8th edition study of TNM in lung cancer. These new attributes are collected from SEER databases, Indian cancer hospitals and research centers. The collected new attributes are classified using supervised machine learning algorithms of linear regression, Naïve Bayes classifier and proposed algorithms of Gaussian K-Base NB classifier. In particular, for TNM stage 1 group of people with normal hemoglobin level (NHBL), that group of lung cancer patient quality of life is highly enhanced. Which proved by using supervised machine learning algorithms. The proposed algorithm classified the database in terms of with respect to tumor size and HB level and the results are confirmed in the R environment. The continuous attribute classification method to prove first level of TNM in lung cancer patient along with standard hemoglobin has to be maintained that the people survivability rate is higher than the smaller level of hemoglobin people survival rate. The Gaussian K-Base NB classifier is more effective than the existing machine learning algorithms for lung cancer prediction model. The proposed classification accuracy has measured using ROC methods.

Entities:  

Keywords:  Gaussian K-base NB classifier; Hemoglobin level; Lung cancer; TNM stage

Year:  2019        PMID: 31127444     DOI: 10.1007/s10916-019-1297-2

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  6 in total

1.  Survival Prediction Model for Patients with Esophageal Squamous Cell Carcinoma Based on the Parameter-Optimized Deep Belief Network Using the Improved Archimedes Optimization Algorithm.

Authors:  Yanfeng Wang; Wenhao Zhang; Junwei Sun; Lidong Wang; Xin Song; Xueke Zhao
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

2.  Survivability Prognosis for Lung Cancer Patients at Different Severity Stages by a Risk Factor-Based Bayesian Network Modeling.

Authors:  Kung-Jeng Wang; Jyun-Lin Chen; Kun-Huang Chen; Kung-Min Wang
Journal:  J Med Syst       Date:  2020-02-10       Impact factor: 4.460

3.  Classify multicategory outcome in patients with lung adenocarcinoma using clinical, transcriptomic and clinico-transcriptomic data: machine learning versus multinomial models.

Authors:  Fei Deng; Lanlan Shen; He Wang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

4.  Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review.

Authors:  Paula Dhiman; Jie Ma; Constanza L Andaur Navarro; Benjamin Speich; Garrett Bullock; Johanna A A Damen; Lotty Hooft; Shona Kirtley; Richard D Riley; Ben Van Calster; Karel G M Moons; Gary S Collins
Journal:  BMC Med Res Methodol       Date:  2022-04-08       Impact factor: 4.615

5.  A Deep Learning-Based Framework for Supporting Clinical Diagnosis of Glioblastoma Subtypes.

Authors:  Sana Munquad; Tapas Si; Saurav Mallik; Asim Bikas Das; Zhongming Zhao
Journal:  Front Genet       Date:  2022-03-28       Impact factor: 4.599

6.  Identifying Lung Cancer Risk Factors in the Elderly Using Deep Neural Networks: Quantitative Analysis of Web-Based Survey Data.

Authors:  Songjing Chen; Sizhu Wu
Journal:  J Med Internet Res       Date:  2020-03-17       Impact factor: 7.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.